Prelude Therapeutics Inc (PRLD) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering Prelude Therapeutics Inc.
|Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
The Trend in the Analyst Price Target
Over the past 44 days, PRLD's average price target has gone up $3.
PRLD Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- The upside potential (average analyst target price relative to current price) of PRLD is higher than 6.28% of all US stocks.
- The average analyst price target of PRLD is higher than 83.64% of stocks in the small market cap category.
- PRLD has a higher number of analysts covering the stock than 24% of Pharmaceutical Products stocks.
- PRLD has a lower variance in analysts' estimates than 24.25% of stocks in the small market cap category.
- PRLD has a greater NA than practically none of all US stocks.
In the Pharmaceutical Products industry, CBPO, PAHC and LCI are the three stocks most similar to Prelude Therapeutics Inc regarding the price target and analyst recommendation information presented here.
Is PRLD a Buy, Hold or Sell? See the POWR Ratings now!